Total Payments
$566,699
2024 Payments
$510.02
Companies
25
Transactions
1,188
Medicare Patients
3,882
Medicare Billing
$243,535
Payment Breakdown by Category
Other$412,955 (72.9%)
Travel$93,970 (16.6%)
Consulting$40,609 (7.2%)
Food & Beverage$18,521 (3.3%)
Education$581.55 (0.1%)
Research$62.61 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $412,955 | 174 | 72.9% |
| Travel and Lodging | $93,970 | 346 | 16.6% |
| Consulting Fee | $40,609 | 18 | 7.2% |
| Food and Beverage | $18,521 | 636 | 3.3% |
| Education | $581.55 | 13 | 0.1% |
| Unspecified | $62.61 | 1 | 0.0% |
Payments by Type
General
$566,637
1,187 transactions
Research
$62.61
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $197,742 | 402 | $0 (2021) |
| Celgene Corporation | $145,874 | 157 | $0 (2019) |
| ABBVIE INC. | $112,512 | 300 | $0 (2024) |
| Amgen Inc. | $41,436 | 62 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $25,737 | 136 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $21,494 | 24 | $0 (2018) |
| PFIZER INC. | $15,623 | 32 | $0 (2019) |
| Janssen Biotech, Inc. | $4,797 | 25 | $0 (2024) |
| GENZYME CORPORATION | $333.83 | 8 | $0 (2024) |
| LEO Pharma Inc. | $236.57 | 17 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $510.02 | 23 | Janssen Biotech, Inc. ($244.67) |
| 2023 | $630.15 | 11 | Amgen Inc. ($332.52) |
| 2022 | $28,530 | 79 | Amgen Inc. ($27,733) |
| 2021 | $11,080 | 53 | AbbVie Inc. ($4,886) |
| 2020 | $23,560 | 78 | Lilly USA, LLC ($12,126) |
| 2019 | $161,554 | 318 | Lilly USA, LLC ($57,087) |
| 2018 | $181,547 | 315 | Celgene Corporation ($57,303) |
| 2017 | $159,289 | 311 | Lilly USA, LLC ($68,508) |
All Payment Transactions
1,188 individual payment records from CMS Open Payments — Page 1 of 48
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.96 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Immunology | ||||||
| 11/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.12 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.16 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.17 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $64.95 | General |
| Category: Immunology | ||||||
| 10/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.81 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: IMMUNOLOGY | ||||||
| 09/30/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Dermatology | ||||||
| 09/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.22 | General |
| Category: Immunology | ||||||
| 08/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.25 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $7.31 | General |
| Category: IMMUNOLOGY | ||||||
| 06/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Immunology | ||||||
| 06/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: IMMUNOLOGY | ||||||
| 06/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.17 | General |
| Category: IMMUNOLOGY | ||||||
| 06/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: IMMUNOLOGY | ||||||
| 06/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.15 | General |
| Category: IMMUNOLOGY | ||||||
| 05/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: IMMUNOLOGY | ||||||
| 05/10/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Dermatology | ||||||
| 04/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $82.95 | General |
| Category: Immunology | ||||||
| 03/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $96.77 | General |
| Category: Immunology | ||||||
| 02/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: Immunology | ||||||
| 01/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.42 | General |
| Category: IMMUNOLOGY | ||||||
| 11/17/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.60 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2023 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $109.71 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 480 | 681 | $80,542 | $34,795 |
| 2022 | 12 | 880 | 1,332 | $138,378 | $56,720 |
| 2021 | 14 | 1,219 | 1,723 | $172,941 | $77,759 |
| 2020 | 12 | 1,303 | 1,798 | $193,765 | $74,262 |
Total Patients
3,882
Total Services
5,534
Medicare Billing
$243,535
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 162 | 267 | $28,885 | $15,198 | 52.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 81 | 94 | $14,006 | $5,917 | 42.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 32 | 49 | $6,637 | $3,823 | 57.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 61 | 74 | $7,010 | $2,599 | 37.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 38 | 38 | $6,260 | $2,368 | 37.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 38 | 51 | $8,772 | $2,018 | 23.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 15 | 16 | $3,488 | $1,279 | 36.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 19 | 24 | $1,944 | $789.98 | 40.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 11 | 11 | $1,545 | $531.10 | 34.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 23 | 57 | $1,995 | $272.08 | 13.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 257 | 411 | $39,661 | $22,745 | 57.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 169 | 208 | $32,774 | $13,086 | 39.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 72 | 110 | $9,284 | $3,686 | 39.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 57 | 57 | $8,448 | $3,630 | 43.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 89 | 108 | $17,207 | $3,252 | 18.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 77 | 98 | $7,782 | $3,154 | 40.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 30 | 42 | $8,967 | $2,984 | 33.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 21 | 34 | $4,141 | $2,299 | 55.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 57 | 201 | $5,947 | $751.02 | 12.6% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2022 | 18 | 21 | $2,173 | $564.50 | 26.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 16 | 16 | $1,870 | $548.84 | 29.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 17 | 26 | $124.00 | $20.38 | 16.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 244 | 339 | $33,196 | $20,016 | 60.3% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 208 | 224 | $34,700 | $14,402 | 41.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 110 | 120 | $17,724 | $10,199 | 57.5% |
About Dr. Eugene Conte, DO
Dr. Eugene Conte, DO is a Dermatology healthcare provider based in Centerville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316056567.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eugene Conte, DO has received a total of $566,699 in payments from pharmaceutical and medical device companies, with $510.02 received in 2024. These payments were reported across 1,188 transactions from 25 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($412,955).
As a Medicare-enrolled provider, Conte has provided services to 3,882 Medicare beneficiaries, totaling 5,534 services with total Medicare billing of $243,535. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatology
- Location Centerville, OH
- Active Since 08/30/2006
- Last Updated 12/20/2013
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1316056567
Products in Payments
- TALTZ (Drug) $175,294
- Otezla (Drug) $175,185
- Humira (Biological) $79,348
- COSENTYX (Biological) $25,591
- STELARA (Biological) $16,637
- EUCRISA (Drug) $15,623
- Skyrizi (Biological) $11,773
- Tremfya (Drug) $4,398
- HUMIRA (Biological) $3,886
- SKYRIZI (Biological) $1,893
- TREMFYA (Drug) $411.66
- DUPIXENT (Biological) $274.38
- RINVOQ (Biological) $237.50
- ENSTILAR (Drug) $189.53
- DUPIXENT (Drug) $158.48
- Cimzia (Drug) $150.34
- SILIQ (Drug) $123.50
- GUSELKUMAB (Biological) $118.92
- ACZONE (Drug) $118.63
- QBREXZA (Drug) $97.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Centerville
Dr. Karl Kellawan, M.d, M.D
Dermatology — Payments: $23,291
Dermatology $23,291
Dr. Barbara Cortez, D.o, D.O
Dermatology — Payments: $19,895
Dermatology $19,895
Dr. Gary Palmer, Md, MD
Dermatology — Payments: $8,919
Dermatology $8,919
Patricia Dickerson, Md, MD
Dermatology — Payments: $1,182
Dermatology $1,182
Dr. Audrey Rutherford, Md, MD
Dermatology — Payments: $565.33
Dermatology $565.33
William Abildgaard, Md, MD
Dermatology — Payments: $219.73
Dermatology $219.73